Literature DB >> 28496048

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke.

Genjiro Kimura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28496048     DOI： 10.1253/circj.CJ-17-0040

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  3 in total

1.  Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database.

Authors:  Wolfgang Rathmann; Karel Kostev
Journal:  Acta Diabetol       Date:  2022-08-06       Impact factor: 4.087

2.  Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Wen-Hsuan Tsai; Shih-Ming Chuang; Sung-Chen Liu; Chun-Chuan Lee; Ming-Nan Chien; Ching-Hsiang Leung; Shu-Jung Liu; Hong-Mou Shih
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

3.  Safety and Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitor Combined with Medical Nutrition Therapy for Hyperglycemia in Acute Stroke: A Retrospective Study.

Authors:  Takahisa Mori; Kazuhiro Yoshioka; Yuhei Tanno; Shigen Kasakura
Journal:  Metabolites       Date:  2021-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.